AbbVie, Inc. (ABBV)

230.01 +1.22 (+0.53%) USD  |  NYSE  |  Dec 24, 12:59
230.00 -0.01 (-0.00%) After-Hours: 13:59
More

AbbVie SG&A Expense (TTM): 13.97B for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for ABBV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Amgen, Inc. 6.976B
Biogen, Inc. 2.431B
Gilead Sciences, Inc. 5.886B
Johnson & Johnson 23.38B
Eli Lilly & Co. 10.39B